Nanexa AB (OSTO:NANEXA) 3-Year Revenue Growth Rate : 57.10% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB 3-Year Revenue Growth Rate?

Nanexa AB's Revenue per Share for the three months ended in Mar. 2024 was kr0.06.

During the past 12 months, Nanexa AB's average Revenue per Share Growth Rate was 97.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 57.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 37.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Nanexa AB was 126.10% per year. The lowest was -39.60% per year. And the median was 33.60% per year.

Competitive Comparison of Nanexa AB's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Nanexa AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanexa AB's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanexa AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanexa AB's 3-Year Revenue Growth Rate falls into.

Nanexa AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Nanexa AB (OSTO:NANEXA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Nanexa AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanexa AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanexa AB (OSTO:NANEXA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Virdings Alle 32B, Uppsala, SWE, 75450

Website

https://www.nanexa.com

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB (OSTO:NANEXA) Headlines

No Headlines